Image

Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease

Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease

Recruiting
6-18 years
All
Phase N/A

Powered by AI

Overview

The study is 3 arms observational study with no intervention that aims to understand the link between Crohn's disease, microbiome and diet in children.

150 children newly diagnosed with Crohn's disease will participate in the study and their data will be used to create an algorithm about their microbiome, disease, diet, etc.

100 other children newly diagnosed will participate in the study and their data will be use to validate the algorithm.

The investigators will be recruiting 50 healthy participants: 20 that are undergoing an endoscopy for abdominal pain and 30 that comes to the physician for different reasons.

After parental consent, the participants will receive an explanation of the study and sign a consent form for colonoscopy. Before colonoscopy, participants will bring fecal samples, give blood samples, biopsies and biopsy brushes (superficial scraping of the tissue) will be taken during the operation. These samples will be retained until further consent is obtained for further study.

After receiving the results of the colonoscopy, children who have been diagnosed with Crohn's disease will be offered to participate in the second part of the study, they will receive an explanation about the app, collection of fecal samples at home, diet logs and anthropometric measurements, demographic information, medical and family history will be registered.

During the first 3 months: the participants will be asked to log data in the app and collect fecal samples at home. They will be asked to come for a follow up visit where anthropomorphic measurements and blood samples will be taken.

Participants will be asked to log in every day to report in the app daily activity and food intake throughout the study period. Each week, the research coordinator will call on participants to make sure the app is correctly filled in, collect the stool samples correctly and answer questions. During the entire study participants will collect fecal samples, every first week of the month participants will enter information in the app.

For children who have not been diagnosed with Crohn's disease by the colonoscopy, or children who visit the institute for reasons other than inflammatory bowel disease without a clear finding will participate in the study control group. If consent is given, fecal samples will be collected at the entrance of the study and after one year, blood samples, a food questionnaire and anthropometric indices, demographic information, medical and family history will be completed.

Eligibility

Inclusion Criteria:

  • CD study group - 'Consent form - Part 1'
    1. Children with clinical suspicion for CD.
    2. Between 6 and 18 years of age.
    3. Naïve to any medical or nutritional intervention.

CD study group - 'Consent form - Part 2'

  1. Children with CD confirmed by endoscopy (and based on accepted criteria7)
  2. Between 6 and 18 years of age.
  3. Naïve to any medical or nutritional intervention.
        Control group undergoing endoscopy en between 6 and 18 years of age undergoing colonoscopy
        for non-specific abdominal pain or other non-inflammatory gastrointestinal conditions.
        Control group not undergoing colonoscopy
          1. Children with no symptoms or signs of gastrointestinal disease and no known medical
             conditions.
          2. Children between 6 and 18 years of age. These children will be recruited from general
             pediatric clinics (children attending for routine check-up), orthopedic clinics,
             ophthalmology clinics or schools.
        Exclusion Criteria:
          -  CD study group
               1. Chronic treatment with any drug upon enrolment and the use of systemic
                  antibiotics, probiotics or proton pump inhibitors during 30 days prior to
                  enrollment.
               2. Morbid obesity (BMI > 95th percentile for their age and gender).
               3. Following particular dietary regimen/dietitian consultation/participation in
                  another study.
               4. Chronic use of steroids or immunomodulatory medications prior to CD diagnosis.
               5. Any other chronic disease (e.g. HIV, Cushing disease, acromegaly,
                  hyperthyroidism, etc.), cancer and recent anti-cancer therapy, neuro-psychiatric
                  disorders, coagulation disorders, celiac disease or any other chronic GI
                  disorder.
               6. Gut-related surgery, including bariatric surgery.
               7. Inability of the participant and nuclear family to follow and utilize the
                  smartphone application.
        Control group not undergoing colonoscopy
          1. Children with no symptoms or signs of gastrointestinal disease and no known medical
             conditions.
          2. Children between 6 and 18 years of age. These children will be recruited from general
             pediatric clinics (children attending for routine check-up), orthopedic clinics,
             ophthalmology clinics or schools.
        Control group undergoing endoscopy
          1. Any known chronic illness.
          2. Following particular dietary regimen/dietitian consultation/participation in another
             study.
          3. Chronic treatment with any drug upon enrolment and the use of systemic antibiotics,
             probiotics or proton pump inhibitors during 30 days prior to enrollment.
          4. Gut-related surgery, including bariatric surgery.

Study details
    Crohn Disease

NCT04283864

Weizmann Institute of Science

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.